Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model
The STRAD-Ro52 model assists in identifying MDA5<sup>+</sup>DM patients at risk of developing severe ILD within six months, further optimizing precise disease management and clinical research design.
Authors
- Shixian Chen (ORCID: https://orcid.org/0000-0002-7200-433X)
- Junqing Zhu (ORCID: https://orcid.org/0000-0003-4642-2981)
- Xiao Liang (ORCID: https://orcid.org/0000-0002-2989-6109)
- Xiangliang Tan
- Fei Xiao (ORCID: https://orcid.org/0000-0001-7353-2700)
- Junyuan Zhong (ORCID: https://orcid.org/0009-0003-8845-1251)
- Juan Wu (ORCID: https://orcid.org/0000-0002-7260-6373)
- Rui Chen (ORCID: https://orcid.org/0000-0002-4387-9735)
- Juan Li (ORCID: https://orcid.org/0000-0002-2977-2966)
- Dongsheng Li (ORCID: https://orcid.org/0000-0001-5348-4764)
- Songyuan Zheng (ORCID: https://orcid.org/0000-0002-1578-2805)
- Feilong Chen (ORCID: https://orcid.org/0000-0002-7821-9665)
Institutions
- Hainan University (CN)
- Ganzhou People's Hospital (CN)
- Nanfang Hospital (CN)
- TCM-Intigrated Cancer Center of Southern Medical University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1080/07853890.2024.2440621
- Citations
- 6
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 2.32